VLA-2112

N/A

Report date: 2023/06/26 09:15:24

Base Information

Drug NameVLA-2112
Drug Alias NameVLA-2112
ClassificationVaccines
Mechanisms of ActionEpstein-Barr virus inhibitors
TargetsEpstein-Barr virus
Therapy Area/IndicationsEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesValneva SE
China Registration ClassN/A

Develop Information

Active CompaniesValneva SE
Inactive CompaniesN/A
Active IndicationsEpstein-Barr Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A